$VNJA
VANJIA CORP

2023 Q4 Form 10-K Financial Statement

#000101738624000046 Filed on March 27, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022
Revenue $7.220K $82.72K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.870K $9.300K $11.41K
YoY Change -6.97% -18.49% -64.75%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.870K $9.300K $11.41K
YoY Change -6.97% -18.49% -64.75%
Operating Profit $73.42K -$11.41K
YoY Change -743.35% -738.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $5.360K $73.42K -$11.41K
YoY Change -366.67% -743.47% -737.43%
Income Tax
% Of Pretax Income
Net Earnings $5.360K $65.73K -$11.41K
YoY Change -366.67% -675.95% -737.54%
Net Earnings / Revenue 74.24% 79.46%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 6.000M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.57K $22.57K $18.13K
YoY Change 24.49% 24.49% -38.65%
Cash & Equivalents $22.57K $22.57K $18.13K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $68.99K $68.99K $0.00
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $91.55K $91.55K $18.13K
YoY Change 404.87% 404.96% -38.65%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $742.0K $742.0K $742.0K
YoY Change 0.0% 0.0% 0.0%
Other Assets
YoY Change
Total Long-Term Assets $742.0K $742.0K $742.0K
YoY Change 0.0% 0.0% 0.0%
TOTAL ASSETS
Total Short-Term Assets $91.55K $91.55K $18.13K
Total Long-Term Assets $742.0K $742.0K $742.0K
Total Assets $833.6K $833.6K $760.1K
YoY Change 9.66% 9.66% -1.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $0.00 $0.00
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $0.00 $0.00
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $0.00 $0.00 $0.00
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$105.8K
YoY Change -40.96%
Common Stock $3.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $833.6K $833.6K $760.1K
YoY Change
Total Liabilities & Shareholders Equity $833.6K $833.6K $760.1K
YoY Change 9.66% 9.66% -1.48%

Cashflow Statement

Concept 2023 Q4 2023 2022
OPERATING ACTIVITIES
Net Income $5.360K $65.73K -$11.41K
YoY Change -366.67% -675.95% -737.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $4.430K $4.434K -$11.41K
YoY Change -320.4% -138.85% -737.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities 4.430K $4.434K -$11.41K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash 4.430K $4.434K -$11.41K
YoY Change -320.4% -138.85%
FREE CASH FLOW
Cash From Operating Activities $4.430K $4.434K -$11.41K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001532383
CY2023Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
usd
CY2022 us-gaap Revenues
Revenues
usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023 us-gaap Interest Paid
InterestPaid
usd
CY2022 us-gaap Interest Paid
InterestPaid
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
usd
CY2023Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
usd
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-179302
CY2023 dei Entity Registrant Name
EntityRegistrantName
Vanjia Corporation
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
TX
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-3051284
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
4771 Sweetwater Blvd
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
 #199
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Sugar Land
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77479
CY2023 dei City Area Code
CityAreaCode
713
CY2023 dei Local Phone Number
LocalPhoneNumber
898-6818
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6000000 shares
CY2020Q4 dei Entity Public Float
EntityPublicFloat
60000 usd
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Auditor Name
AuditorName
Yusufali & Associates, LLC
CY2023 dei Auditor Location
AuditorLocation
Short Hills, New Jersey 07078
CY2023 dei Auditor Firm
AuditorFirmId
3313
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22568 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18134 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
68985 usd
CY2022Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
0 usd
CY2023Q4 vnja Land Held For Investment
LandHeldForInvestment
742000 usd
CY2022Q4 vnja Land Held For Investment
LandHeldForInvestment
742000 usd
CY2023Q4 us-gaap Assets
Assets
833553 usd
CY2022Q4 us-gaap Assets
Assets
760134 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8888888888 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8888888888 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9999999999 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9999999999 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30000000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
936400 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
936400 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105847 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-179266 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
833553 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
760134 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
833553 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
760134 usd
CY2023 us-gaap Revenues
Revenues
82720 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9301 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11412 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
73419 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-11412 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
73419 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11412 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
30000000 shares
CY2022 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
30000000 shares
CY2023 us-gaap Net Income Loss
NetIncomeLoss
73419 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11412 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
68985 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4434 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11412 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4434 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-11412 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18134 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29546 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
22568 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18134 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
771546 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-11412 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
760134 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
760134 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
73419 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
833553 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-105847 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
73419 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zCzn8PytMgEe" style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><span style="background-color: white"><b>Note 2: Use of Estimates</b></span></p> <p style="font: 11pt Times New Roman, Times, Serif; margin: 0pt 0 12pt"><span style="background-color: white">The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</span></p>
CY2023Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
105847 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0 pure
CY2023Q4 us-gaap Deferred Tax Assets Other Loss Carryforwards
DeferredTaxAssetsOtherLossCarryforwards
11412 usd
CY2022Q4 us-gaap Deferred Tax Assets Other Loss Carryforwards
DeferredTaxAssetsOtherLossCarryforwards
11412 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11412 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
11412 usd
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
5000000 usd
CY2022 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.03 pure
CY2023Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
0 usd
CY2022Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
0 usd

Files In Submission

Name View Source Status
0001017386-24-000046-index-headers.html Edgar Link pending
0001017386-24-000046-index.html Edgar Link pending
0001017386-24-000046.txt Edgar Link pending
0001017386-24-000046-xbrl.zip Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vnja-20231231.xsd Edgar Link pending
vnja_2023dec31-10k.htm Edgar Link pending
vnja-20231231_def.xml Edgar Link unprocessable
vnja-20231231_lab.xml Edgar Link unprocessable
vnja-20231231_pre.xml Edgar Link unprocessable
vnja_2023dec31-10k_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
vnja-20231231_cal.xml Edgar Link unprocessable